PMV Pharmaceuticals, Inc

PMVP

...

PMVP: PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Show PMVP Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of PMVP by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by PMVP's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Methods and compounds for restoring mutant p53 function Aug. 22, 2023
Patent Title: Methods and compounds for restoring mutant p53 function May. 24, 2022
Patent Title: Methods and compounds for restoring mutant p53 function May. 05, 2020
Patent Title: Methods and compounds for restoring mutant p53 function Nov. 27, 2018

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on PMVP's company Twitter account

WallStreetBets

Number of mentions of PMVP in WallStreetBets Daily Discussion

PMVP News

Recent insights relating to PMVP

CNBC Recommendations

Recent picks made for PMVP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in PMVP

Corporate Flights

Flights by private jets registered to PMVP